These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15935907)

  • 1. p-Aminobenzoic acid derivatives as acetylcholinesterase inhibitors.
    Correa-Basurto J; Alcántara IV; Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Eur J Med Chem; 2005 Jul; 40(7):732-5. PubMed ID: 15935907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, anticholinesterase activity and structure-activity relationships of m-Aminobenzoic acid derivatives.
    Trujillo-Ferrara J; Montoya Cano L; Espinoza-Fonseca M
    Bioorg Med Chem Lett; 2003 May; 13(10):1825-7. PubMed ID: 12729674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.
    Muñoz-Ruiz P; Rubio L; García-Palomero E; Dorronsoro I; del Monte-Millán M; Valenzuela R; Usán P; de Austria C; Bartolini M; Andrisano V; Bidon-Chanal A; Orozco M; Luque FJ; Medina M; Martínez A
    J Med Chem; 2005 Nov; 48(23):7223-33. PubMed ID: 16279781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer's disease.
    Sadashiva CT; Narendra Sharath Chandra JN; Ponnappa KC; Veerabasappa Gowda T; Rangappa KS
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3932-6. PubMed ID: 16735118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.
    Piazzi L; Cavalli A; Colizzi F; Belluti F; Bartolini M; Mancini F; Recanatini M; Andrisano V; Rampa A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):423-6. PubMed ID: 17998161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease.
    Lin HQ; Ho MT; Lau LS; Wong KK; Shaw PC; Wan DC
    Chem Biol Interact; 2008 Sep; 175(1-3):352-4. PubMed ID: 18573242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoquinoline derivatives as potential acetylcholinesterase inhibitors.
    Markmee S; Ruchirawat S; Prachyawarakorn V; Ingkaninan K; Khorana N
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2170-2. PubMed ID: 16483771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease.
    Melchiorre C; Andrisano V; Bolognesi ML; Budriesi R; Cavalli A; Cavrini V; Rosini M; Tumiatti V; Recanatini M
    J Med Chem; 1998 Oct; 41(22):4186-9. PubMed ID: 9784091
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush.
    Rosini M; Simoni E; Bartolini M; Cavalli A; Ceccarini L; Pascu N; McClymont DW; Tarozzi A; Bolognesi ML; Minarini A; Tumiatti V; Andrisano V; Mellor IR; Melchiorre C
    J Med Chem; 2008 Aug; 51(15):4381-4. PubMed ID: 18605718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE.
    Alonso D; Dorronsoro I; Rubio L; Muñoz P; García-Palomero E; Del Monte M; Bidon-Chanal A; Orozco M; Luque FJ; Castro A; Medina M; Martínez A
    Bioorg Med Chem; 2005 Dec; 13(24):6588-97. PubMed ID: 16230018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/butyrylcholinesterase and modulators of Ca2+ channels and nicotinic receptors.
    Marco JL; de los Ríos C; García AG; Villarroya M; Carreiras MC; Martins C; Eleutério A; Morreale A; Orozco M; Luque FJ
    Bioorg Med Chem; 2004 May; 12(9):2199-218. PubMed ID: 15080920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates.
    Fang L; Kraus B; Lehmann J; Heilmann J; Zhang Y; Decker M
    Bioorg Med Chem Lett; 2008 May; 18(9):2905-9. PubMed ID: 18406135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
    da Silva CH; Campo VL; Carvalho I; Taft CA
    J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.
    Arce MP; Rodríguez-Franco MI; González-Muñoz GC; Pérez C; López B; Villarroya M; López MG; García AG; Conde S
    J Med Chem; 2009 Nov; 52(22):7249-57. PubMed ID: 19856923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-alzheimer drug ganstigmine (CHF-2819).
    Bartolucci C; Siotto M; Ghidini E; Amari G; Bolzoni PT; Racchi M; Villetti G; Delcanale M; Lamba D
    J Med Chem; 2006 Aug; 49(17):5051-8. PubMed ID: 16913695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.
    Girisha HR; Narendra Sharath Chandra JN; Boppana S; Malviya M; Sadashiva CT; Rangappa KS
    Eur J Med Chem; 2009 Oct; 44(10):4057-62. PubMed ID: 19493592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl 2-(2-(4-formylphenoxy)acetamido)-2-substituted acetate derivatives: a new class of acetylcholinesterase inhibitors.
    Wen H; Zhou Y; Lin C; Ge H; Ma L; Wang Z; Peng W; Song H
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2123-5. PubMed ID: 17317172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of organophosphates with fluorine-containing leaving groups as serine esterase inhibitors with potential for Alzheimer disease therapeutics.
    Makhaeva GF; Aksinenko AY; Sokolov VB; Serebryakova OG; Richardson RJ
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5528-30. PubMed ID: 19717305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.